Atrial fibrillation - definition

Atrial fibrillation (AFib) is a common heart arrhythmia characterized by rapid, irregular atrial activity leading to ineffective atrial contraction and irregular ventricular rhythm. It is diagnosed via ECG and increases the risk of stroke and heart failure, making prompt diagnosis and management essential.

Atrial fibrillation (AFib) is the most common sustained cardiac arrhythmia, characterized by rapid and irregular atrial activation. Instead of a coordinated contraction, the atria quiver or fibrillate due to chaotic electrical signals. This uncoordinated activity leads to ineffective atrial emptying and irregular ventricular rhythm. AFib affects millions worldwide and its prevalence increases with age, affecting approximately 9% of individuals over the age of 80. Understanding AFib's definition is crucial for recognizing its symptoms and initiating appropriate management.

The core mechanism behind AFib involves multiple re-entrant wavelets circulating in the atria. These wavelets are self-sustaining electrical circuits that perpetuate the fibrillatory process. In some cases, focal triggers, often originating from the pulmonary veins, initiate and maintain AFib. The electrical disorganization leads to a loss of the atrial "kick," which contributes up to 30% of ventricular filling in healthy hearts. This loss can significantly impact cardiac output, especially in individuals with underlying heart conditions. Furthermore, the rapid and irregular ventricular rate associated with AFib can lead to heart failure and other complications.

Historically, the first documented description resembling AFib dates back to the late 19th century. However, it was not until the advent of electrocardiography (ECG) that its true nature was understood. The ECG hallmark of AFib is the absence of distinct P waves, replaced by irregular fibrillatory waves (f-waves) and an irregularly irregular R-R interval. The development of antiarrhythmic medications and, more recently, catheter ablation techniques, have revolutionized the management of AFib. The understanding of its mechanisms has evolved significantly, leading to more targeted therapies.

The diagnosis of AFib is primarily based on the ECG. The absence of P waves, presence of fibrillatory waves, and irregular R-R intervals are diagnostic hallmarks. However, short episodes of AFib (paroxysmal AFib) may be missed on a standard ECG. In such cases, ambulatory ECG monitoring, such as a Holter monitor or event recorder, may be necessary to capture the arrhythmia. Once diagnosed, further investigations, including echocardiography, are essential to assess the underlying structural heart disease and guide management.

A common misconception is that AFib is a benign condition. While some individuals may experience no symptoms, AFib significantly increases the risk of stroke, heart failure, and other cardiovascular complications. The irregular atrial activity promotes blood clot formation in the left atrial appendage, which can then dislodge and travel to the brain, causing a stroke. Therefore, prompt diagnosis and appropriate management, including anticoagulation to prevent stroke, are crucial.

The irregular and rapid ventricular rate in AFib can lead to several clinical consequences. The rapid heart rate reduces the time for ventricular filling, decreasing cardiac output. This can lead to symptoms such as fatigue, shortness of breath, and dizziness. In individuals with underlying heart conditions, such as heart failure or coronary artery disease, the rapid rate can exacerbate these conditions and lead to decompensation. Rate control, either with medications or ablation, is often a key component of AFib management.

While AFib is commonly associated with heart disease, it can also occur in individuals with structurally normal hearts. This is often referred to as "lone AFib." Potential triggers in such cases include excessive alcohol consumption, caffeine intake, stress, and electrolyte imbalances. Identifying and addressing these triggers can sometimes reduce the frequency or duration of AFib episodes.

The impact of AFib on quality of life can be significant. Symptoms such as palpitations, fatigue, and shortness of breath can limit daily activities and reduce overall well-being. Furthermore, the fear of experiencing AFib episodes can lead to anxiety and depression. Effective management of AFib, including rate control, rhythm control, and stroke prevention, can significantly improve quality of life.

The "atrial kick" lost during AFib is a crucial aspect often underestimated. During normal sinus rhythm, the atria contract to push the last bit of blood into the ventricles before they contract. This atrial contraction contributes to ventricular filling, especially during exercise or times of increased cardiac demand. In AFib, the atria do not contract effectively, leading to a decrease in ventricular filling and reduced cardiac output. This impact is more pronounced in individuals with stiff ventricles or diastolic dysfunction.

AFib is classified into different types based on its duration and frequency: paroxysmal (episodes terminate spontaneously within 7 days), persistent (episodes last longer than 7 days and require intervention to terminate), long-standing persistent (present continuously for more than 12 months), and permanent (AFib is present and no further attempts are made to restore sinus rhythm). This classification helps guide treatment strategies and prognosis. Paroxysmal AFib is often treated with antiarrhythmic medications or ablation, while permanent AFib focuses on rate control and stroke prevention.

Browse public study notes